Bengal CM holds meeting with officials of various departments amid rising cases of COVID, advices citizens to remain cautious
CM Mamata Banerjee said, 'We are hoping that the pandemic won't be repeated. We have conducted a meeting today with senior officials of every department, including Panchayat, Urban, Municipalities, DME, DHS, Health Department, MSME, Police Department, Chief Secretary, Home Secretary, and Kolkata Corporation. We have to be careful. There is no need to panic. We have to be prepared. Those who have comorbidities should consult the doctor. Government is always standing with them. Try to get treatment in a government hospital. It will not cost much. All the facilities are available in the government hospital. Now, the anti-COVID-19 vaccine is available. Everyone is vaccinated. We did the meeting to be cautious in future.'
She further said that the situation is not severe at this point.
'There are 4 to 5 thousand cases in the country. This is a kind of influenza,' she added.
Another health expert present said that this was a subvariant of the omicron virus, and this was not a variant of concern. 'It was like a normal cough and cold and the wave would be over soon,' he said.
According to the Union Health Ministry's data, 59 deaths have been reported since January 1, 2025. States have been instructed to ensure oxygen availability, isolation beds, ventilators, and essential medicines.
Given the recent increase in COVID-19 cases in India, a series of technical review meetings were held on June 2 and 3 with various representatives under the chairpersonship of Dr Sunita Sharma, Director General of Health Services (DGHS).
According to an official statement, the representatives include Disaster Management Cell, Emergency Management Response (EMR) Cell, National Centre for Disease Control (NCDC), Indian Council of Medical Research (ICMR), Integrated Disease Surveillance Programme (IDSP) and Central Government Hospitals in Delhi and with representatives from all States and UTs to evaluate the current COVID-19 situation and preparedness measures. (ANI)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
2 hours ago
- News18
Two-day national conclave FITT Forward 2025 begins tomorrow at IIT Delhi
New Delhi [India], August 20 (ANI): As India moves towards a transformative decade of deep-tech innovations, FITT Forward 2025 (21-22 August 2025, FITT-IIT Delhi campus) is being held at a decisive was organized by the Foundation for Innovation and Technology Transfer (FITT) at IIT Delhi. This two-day national conclave is bringing together deep-tech startups, policymakers, global investors, and research leaders on one platform to further place India on the global innovation map, the release said. Under the guidance of Dr. Nikhil Agarwal, Managing Director, FITT; Prof. Preeti Ranjan Panda, Dean (Corporate Relations); and Prof. Rangan Banerjee, Director, IIT Delhi, FITT Forward 2025 will see innovators, investors, and industry leaders come together to accelerate major changes in India's deep-tech sector. Through collective efforts, emerging ideas will be transformed into practical, scalable conference is set to define the next phase of India's startup journey, aligning with national initiatives such as Startup India, Make in India, and Atmanirbhar two-day platform will see participation from several senior government officials, over 30 early-stage and scaling startups from across the country, investors, and more. During the event, over 20 MoUs, more than 30 startup-investor meetings, and 8-10 CSR partnership announcements are anticipated, a release are several startups making debut in India which will be showcased here;– A cutting-edge bio-processing technology developed in collaboration with IIT Delhi that transforms ordinary fabrics into skin-friendly, herbal wellness garments.– A healthcare innovator launching a portable diagnostic device that can detect proteins in urine, bringing affordable, lab-grade testing to rural areas where economic constraints prevent people from accessing such facilities. – Another startup developing medical simulators for neurosurgery, including brain ventriculostomy and shunt placement, for use in training hospitals across the country.– An innovation bringing a transdermal delivery platform for multi-micronutrients, replacing pills with smart patches that the body absorbs more efficiently.– A healthcare platform that collects real-time data from wearables and alerts users to serious health anomalies even before symptoms appear. – Another startup has built a range of period-care and feminine hygiene products using organic, chemical-free, and skin-safe ingredients.– A new-age fabric will be launched that destroys 99.9% of bacteria and viruses within 30 minutes.– Additionally, India's first robot for swimming pool cleaning and disinfection, already awarded as the best robotics startup, is now ready for public launch. (ANI)
News18
3 hours ago
- News18
Worlds first human spinal cord implant to take place in Israel
Tel Aviv [Israel], August 20 (ANI/TPS): Israel is preparing to perform the world's first-ever human spinal cord implant using a patient's own cells, a medical breakthrough that could allow paralysed patients to stand and walk again, Tel Aviv University announced on surgery, expected in the coming months, will take place in Israel and marks a historic milestone in regenerative to the World Health Organisation, over 15 million people worldwide are living with spinal cord injuries, with the majority resulting from traumatic causes such as falls, road traffic accidents, and spinal cord injuries cannot be fully cured, so treatment focuses on stabilising the patient, preventing further damage, and maximising function. Emergency care often involves immobilising the spine, reducing inflammation, and sometimes performing surgery to repair fractures or relieve pressure. Rehabilitation includes physical and occupational therapy, as well as assistive devices like wheelchairs and braces. While experimental therapies–including stem cells and robotic devices–are being explored, no treatment yet reliably restores full spinal cord cord injuries are one of the few human injuries where the body cannot naturally heal itself, and the tissue is both structurally complex and extremely sensitive.'The spinal cord transmits electrical signals from the brain to all parts of the body. When it is severed by trauma such as a car accident, a fall, or a combat injury, the chain is broken. Think of an electrical cable that has been cut: when the two ends no longer touch, the signal cannot pass, and the patient remains paralysed below the injury," explained Professor Tal Dvir, head of the Sagol Centre for Regenerative Biotechnology and the Nanotechnology Centre at Tel Aviv University, who is leading the effort. Dvir is also the chief scientist at Matricelf, the Israeli biotech company commercialising the other tissues, spinal cord neurons cannot naturally regenerate, and over time, scar tissue blocks remaining signals. The new procedure aims to replace the damaged section with a lab-grown spinal cord that fuses with healthy tissue above and below the injury. Animal studies in rats have shown remarkable results, with the animals regaining the ability to walk innovation began about three years ago, when Dvir's lab engineered a personalised three-dimensional human spinal cord in the laboratory. The findings, published in the peer-reviewed journal Advanced Science, showed that mice with chronic paralysis regained mobility after receiving the engineered procedure begins with blood cells from the patient, which are reprogrammed into stem-cell-like cells capable of becoming any cell type. Fat tissue is also collected to create a custom hydrogel scaffold, into which the stem-like cells develop into a spinal cord structure. This engineered tissue is then implanted, replacing scarred areas and reconnecting the nervous system.A few months ago, Prof. Dvir and his team received preliminary approval from Israel's Ministry of Health for 'compassionate use" trials in eight patients, making Israel the first country to attempt this procedure. 'This is undoubtedly a matter of national pride. The technology was developed here in Israel, at Tel Aviv University and at Matricelf, and from the very beginning it was clear to us that the first-ever surgery would be performed in Israel, with an Israeli patient," Dvir technology was then commercialised through Matricelf, which was founded in 2019 under a licensing agreement with Tel Aviv University's technology transfer company, Ramot.'This milestone marks the shift from pioneering research to patient treatment. Using each patient's own cells eliminates key safety risks and positions Matricelf at the forefront of regenerative medicine. This first procedure is more than a scientific breakthrough; it is a step toward transforming an area of medicine long considered untreatable," said Matricelf CEO Gil added, 'If successful, this therapy could define a new standard of care in spinal cord repair, addressing a multi-billion-dollar market with no effective solutions today. We are proud that Israel is leading this global effort and are fully committed to bringing this innovation to patients worldwide."'Our goal is to help paralysed patients rise from their wheelchairs. The animal model trials showed extraordinary success, and we are hopeful that the results in humans will be just as promising," Dvir said. (ANI/TPS)
Time of India
6 hours ago
- Time of India
New COVID variant Stratus (XFG) spreads in the US: Symptoms, risks, and what you need to know
As the United States experiences another wave of COVID-19, a variant named Stratus (XFG) has caught the attention of health authorities. Officially identified as XFG, this recombinant strain was first detected in Southeast Asia in January 2025. While initially flying under the radar in the US, XFG accounted for 14% of all cases by late June, making it the third most prevalent variant according to the Centers for Disease Control and Prevention (CDC). Globally, the World Health Organization ( WHO ) has added XFG to its monitoring list, though it continues to classify the variant's overall public health risk as low. Experts reassure that current COVID-19 vaccines remain effective against symptomatic and severe disease caused by this strain. What is the new covid variant in the US Stratus (XFG) and how is it different XFG is a recombinant variant, meaning it combines genetic material from two earlier strains: F.7 and LP.8.1.2. While LP.8.1.2 is now the second most common strain in the US, XFG is notable for its mutations that may help it evade the immune system. Importantly, experts emphasize that these mutations do not make XFG more dangerous. According to Dr. Subhash Verma, microbiology and immunology professor at the University of Nevada, XFG does not cause more severe illness or different symptoms compared to earlier Omicron variants. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Use an AI Writing Tool That Actually Understands Your Voice Grammarly Install Now Undo Health authorities classify the variant as low risk, but continued monitoring is essential to track its evolution. How fast is this covid variant As reported by USA Today, XFG's prevalence in the US has increased rapidly in recent months: March 2025: 0% of cases April 2025: 2% of cases May 2025: 6% of cases Late June 2025: 14% of cases Globally, the WHO reported a rise from 7.4% in early May to 22.7% by the end of June across 38 countries. Despite this growth, XFG has not surpassed the top two variants, but its upward trend underscores the importance of ongoing genomic surveillance and vaccine coverage. Symptoms of Stratus (XFG) variant As USA Today reported, know the familiar COVID-19 symptoms for XFG infections. These include: Fever or chills Cough Fatigue Sore throat Loss of taste or smell Nasal congestion Muscle aches Shortness of breath Headache Nausea or vomiting Health officials stress that symptom patterns remain consistent with prior Omicron variants, and early testing, vaccination, and isolation are key to controlling spread. Prevention tips for Stratus (XFG) variant To reduce the risk of infection from the XFG variant (Stratus), follow these recommended safety measures: Stay up to date with COVID-19 vaccines: Ensure primary doses and booster shots are current, as vaccines remain effective against severe disease. Practice good hygiene: Regular handwashing, using hand sanitizer, and avoiding touching the face can reduce transmission. Wear masks in crowded or enclosed spaces: Especially in public transport, healthcare facilities, or areas with high case counts. Maintain physical distancing: Avoid close contact with people showing respiratory symptoms. Monitor symptoms and test early: Get tested if you experience fever, cough, fatigue, or other COVID-related symptoms. Isolate if infected: Follow local health guidelines to prevent spreading the virus to others. Ventilate indoor spaces: Increase airflow in homes, offices, and public spaces to reduce viral concentration. Disclaimer : The information provided in this article is for general educational purposes only and is based on data available from the reputable news sources as of August 2025. It should not be considered medical advice. Always consult healthcare professionals for personal guidance on COVID-19 prevention, testing, and treatment. Also read | Sudden cardiac arrest in gyms: Causes, prevention tips, and urgent advisory issued for young athletes by Punjab government
